Physician profile
Ryan S Levey
NPI 1861755662
$1,611.31
in general payments reported to CMS, 2019-2025
25 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.32 · 2021: $195 · 2022: $459 · 2023: $433 · 2024: $384 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $937.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $183.19 | 2022-2023 | Urolift |
| Astellas Pharma US INC | $177.83 | 2021-2024 | Xtandi |
| Antares Pharma, INC. | $139.62 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Myriad Genetic Laboratories, INC. | $136.00 | 2022-2023 | Prolaris |
| Boston Scientific Corporation | $135.78 | 2022-2025 | Tria Firm, Watchman Flx |
| 180 Medical, INC. | $127.08 | 2021-2024 | Gentlecath |
| Agiliti Surgical, INC. | $97.83 | 2024 | Koelis Trinity Fusion Biopsy System, Sonablate Hifu |
| Abbvie INC. | $69.90 | 2023-2024 | |
| Halozyme INC | $64.51 | 2023 | |
| Progenics Pharmaceuticals, INC. | $57.49 | 2022-2023 | Pylarify |
| Endo Pharmaceuticals INC. | $52.42 | 2021-2022 | |
| Convatec INC. | $45.95 | 2021-2022 | |
| Medtronic, INC. | $40.48 | 2025 | Interstim |
| Procept Biorobotics Corporation | $38.93 | 2024 | Aquabeam System |
| Olympus America INC. | $34.46 | 2024 | Itind System |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $32.86 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Endo USA, INC. | $27.81 | 2025 | Aveed, Xiaflex |
| Axonics, INC. | $25.79 | 2023 | Axonics |
| Ambu INC. | $24.25 | 2024 | |
| Calyxo, INC. | $20.40 | 2023 | Cvac Aspiration System |
| Pfizer INC. | $19.32 | 2020 | |
| Tolmar, INC. | $16.39 | 2025 | Eligard, Jatenzo |
| Coloplast Corp | $15.79 | 2023 | Porges Coloplast |
| Urovant Sciences INC | $14.12 | 2022 | |
| Allergan, INC. | $13.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Levey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.